Literature DB >> 21208325

Australia's experience with varenicline: usage, costs and adverse reactions.

Raoul A Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21208325     DOI： 10.1111/j.1360-0443.2010.03282.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  3 in total

1.  Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications.

Authors:  Ron Borland; Timea R Partos; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2012-02-07       Impact factor: 4.244

Review 2.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Nicola Lindson-Hawley; Kyla H Thomas; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

3.  Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.

Authors:  Laura J Rosen; Tal Galili; Jeffrey Kott; Mark Goodman; Laurence S Freedman
Journal:  Addiction       Date:  2018-01-29       Impact factor: 6.526
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.